▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Maxx Chatsko

XMFBlacknGoldX

Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.

Recent Articles by Maxx Chatsko

stock up bar chart getty

Sep 8, 2019 by Maxx Chatsko

Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August

The biopharma announced fiscal third-quarter 2019 operating results and multiple updates from the pipeline.

stock down angry fist

Sep 8, 2019 by Maxx Chatsko

Here's Why Myriad Genetics Dropped 19.2% in August

The genetic testing leader took investors on a wild ride last month.

businessman rocket

Sep 8, 2019 by Maxx Chatsko

Here's Why Tandem Diabetes Care Jumped 14.2% in August

The medical device company is cruising past everyone's expectations -- including its own.

356 wind turbines field

Sep 7, 2019 by Maxx Chatsko

Why U.S. Renewable Energy Production Declined 1.1% in the First Half of 2019

And why investors shouldn't panic.

201 wind turbines mountain

Sep 7, 2019 by Maxx Chatsko

2 Top Renewable Energy Stocks to Buy in Wind Power

Between them, they are responsible for 24,000 megawatts of wind power capacity -- 25% of the U.S. total.

464 diesel truck

Sep 6, 2019 by Maxx Chatsko

Here's Why Renewable Energy Group Should Go All-In on Renewable Diesel

It's time for the business to begin transitioning away from biodiesel and toward more future-proof (and profitable) products.

031 lithium brine

Sep 6, 2019 by Maxx Chatsko

Here's Why Albemarle Dropped 12.3% in August

The company reported solid second-quarter 2019 operating results, but significantly reduced production expansion plans.

469 wind turbines on mountain

Sep 6, 2019 by Maxx Chatsko

Here's Why Pattern Energy Group Rose 17.6% in August

The company confirmed that it has been approached for a takeover, but nothing is guaranteed.

353 doctor boxing gloves

Sep 6, 2019 by Maxx Chatsko

2 Stocks to Watch in September

These two businesses could receive a big boost this month if certain events fall in their favor.

stock down erased chalkboard

Sep 5, 2019 by Maxx Chatsko

Here's Why Enphase Energy Keeps Tumbling

The solar-hardware stock has now given up all gains since second-quarter 2019 operating results were announced.

stock down finger

Sep 5, 2019 by Maxx Chatsko

Here's Why Mallinckrodt Is Collapsing Today

The company is reportedly considering bankruptcy to cope with its financial exposure in the opioid crisis.

220 road ahead

Sep 5, 2019 by Maxx Chatsko

Where Will Epizyme Be in 1 Year?

The pharma company could earn its first drug approval in January 2020. What happens after that?

120 fish bowl jump

Sep 4, 2019 by Maxx Chatsko

Merger or Not, Pacific Biosciences Needs to Deliver

The DNA sequencing pioneer promised a $1,000 human genome by early 2019. The price isn't so important, but the technology upgrades will prove critical.

248 stethoscope laptop

Sep 4, 2019 by Maxx Chatsko

Near an All-Time Low, Is Clovis Oncology a Buy?

Investors need ongoing clinical trials to deliver -- and for the business to rein in expenses.

465 cardboard box line

Sep 4, 2019 by Maxx Chatsko

Here's My Top Stock to Buy in September

The business is profitable, investing in the future, and pays a healthy annual dividend yielding 5%. Shares look like a bargain, too.

031 hand light bulb

Sep 3, 2019 by Maxx Chatsko, Jason Hall, and Matt DiLallo

3 Stocks Peter Lynch Would Love

These growth stocks are trading at reasonable prices -- exactly the kind of investment the investing guru sought.

410 binoculars kid

Aug 30, 2019 by Maxx Chatsko

ArQule: Buy the Dip?

The pharma company has wowed investors with solid clinical data multiple times this year.

GettyImages-1140327515

Aug 29, 2019 by Maxx Chatsko

Neptune Wellness Solutions: Buy the Dip?

The business might yet prove to be a less risky play on the rise of cannabis, but it has plenty left to prove to investors.

352 dollar arrow

Aug 29, 2019 by Maxx Chatsko, Demitri Kalogeropoulos, and Brian Feroldi

3 Top Stocks Under $20

Your money can buy more shares of these promising companies thanks to an affordable stock price.

businessman rocket

Aug 28, 2019 by Maxx Chatsko

Here's Why Lannett Stock Is Soaring Today

The generic drug manufacturer announced fiscal 2019 results and inked an important supply deal.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services